Waddell & Reed Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Waddell & Reed Financial’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-386,737	Closed	-$5.14M	–	599
2016 Q3	$5.14M	Buy	+386,737	New	+$4.52M	0.01%	514
2014 Q4	–	Sell	-573,120	Closed	-$6.22M	–	572
2014 Q3	$6.22M	Buy	+573,120	New	+$6.56M	0.01%	467
2014 Q2	–	Sell	-1,537,540	Closed	-$15.9M	–	545
2014 Q1	$15.9M	Buy	1,537,540 +10,372	+0.7%	+$117K	0.02%	362
2013 Q4	$14.8M	Sell	1,527,168 -470,269	-24%	-$4.22M	0.02%	361
2013 Q3	$19.8M	Sell	1,997,437 -1,909,983	-49%	-$18.7M	0.04%	313
2013 Q2	$32.6M	Buy	+3,907,420	New	+$47.4M	0.07%	243

Other funds holding IRWD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Waddell & Reed Financial's IRWD Position: Q4 2016 in Review

Waddell & Reed Financial sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2016, closing a stake of 386,737 shares — an estimated $5.14M sold.

Waddell & Reed Financial first reported a position in IRWD in Q2 2013 and held it in 6 quarters. The position peaked at $32.6M in Q2 2013. 163 funds tracked by Wall St. Rank hold IRWD as of Q4 2016.

Waddell & Reed Financial reported no remaining Ironwood Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Waddell & Reed Financial sold 386,737 Ironwood Pharmaceuticals shares in Q4 2016, an estimated $5.14M.
Waddell & Reed Financial first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 6 quarters.
Waddell & Reed Financial's Ironwood Pharmaceuticals position peaked at $32.6M in Q2 2013.
163 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2016.

Based on Waddell & Reed Financial's 13F filing for Q4 2016, filed 14 Feb 2017.